FDA OKs First Drug for Pediatric Neurofibromas

]]>(MedPage Today) -- WASHINGTON--The FDA approved selumetinib (Koselugo) on Friday for the treatment of plexiform neurofibromas in children with neurofibromatosis type 1 (NF1).NF1 is a genetic condition that leads to the growth of tumors throughout...